NCT02816255

Brief Summary

Subjects will all have a two week baseline period in which they will use a nasal mask using an air view CPAP machine (which records all data). After the two week period all will switch to a full face mask with half using the same CPAP pressure and half with a new a CPAP pressure derived from our formula for the final two weeks.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2017

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 23, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 28, 2016

Completed
6 months until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 9, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 9, 2018

Completed
4.6 years until next milestone

Results Posted

Study results publicly available

September 28, 2022

Completed
Last Updated

September 28, 2022

Status Verified

August 1, 2022

Enrollment Period

1.2 years

First QC Date

June 23, 2016

Results QC Date

August 30, 2022

Last Update Submit

August 30, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Severity of Sleep Apnea as Measured by the AHI

    The investigators will compare the Apnoea-Hypopnoea Index (AHI) of subjects with the new formula in place vs. those that don't have the formula. The Apnea-Hypopnea Index is an index used to indicate the severity of sleep apnea. It is represented by the number of apnea and hypopnea events per hour of sleep. A respiratory event is scored as an apnea when both of the following criteria are met: N1, N2, N3, N4. a) There is a drop in the peak signal excursion by greater than or equal to 90% of pre-event baseline using an oronasal thermal sensor (diagnostic study), PAP device flow (titration study) or an alternative apnea sensor (diagnostic study) b) The duration of the greater than or equal to 90% drop in sensor signal is greater than or equal to 10 seconds.

    After a 2-week baseline period (for weeks 3 & 4), subjects will be switched from a nasal to full-face CPAP mask interface for two-weeks with either the same CPAP setting (control) or a new formula determined pressure (treatment).

Secondary Outcomes (1)

  • Lowest Oxyhemoglobin Saturation

    One month

Study Arms (2)

Full Face Mask with same CPAP Pressure

PLACEBO COMPARATOR

After the two week period all will switch to a full face mask with half using the same CPAP pressure.

Device: Full Face Mask with same CPAP Pressure

Full Face Mask with new Pressure

ACTIVE COMPARATOR

After the two week period all will switch to a full face mask with half using with a new cpap pressure derived from our formula.

Device: Full Face Mask with new Pressure

Interventions

Full Face Mask with same CPAP Pressure

Full Face Mask with same CPAP Pressure

New cpap pressure derived from our formula for the final two weeks.

Full Face Mask with new Pressure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • AHI above 15.
  • Willing to switch to full face mask post titration.
  • Not currently on a weight loss plan and no intention of beginning a weight loss regimen during the duration of the study

You may not qualify if:

  • AHI below 15.
  • Not willing to switch to full face mask post titration.
  • Currently on a weight loss plan and / or intention of beginning a weight loss regimen during the duration of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Weill Cornell Medicine Center for Sleep Medicine

New York, New York, 10065, United States

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Results Point of Contact

Title
Matthew R. Ebben, Ph.D.
Organization
Weill Cornell Medicine

Study Officials

  • Matthew Ebben, Ph. D.

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Subjects will complete two week baseline with nasal mask then will complete two week treatment with full face either with new algorithm or old algorithm.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2016

First Posted

June 28, 2016

Study Start

January 1, 2017

Primary Completion

March 9, 2018

Study Completion

March 9, 2018

Last Updated

September 28, 2022

Results First Posted

September 28, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations